Download PDFPDF

P203 A comparison of adverse events associated with licensed and unlicensed spacer use with non-extrafine beclometasone dipropionate treatment in a real-life patient population with asthma in the uk
Free
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address